COVID-19: Therapy used on Donald Trump proves to be 100% effective


Hyderabad: Popular for being administered on US ex-president Donald Trump, the monoclonal therapy has proven to be 100 per cent effective in treating severe diseases and even death in high-risk individuals affected with Delta Variant of SARS COV 2.  The study for confirming the same was conducted by AIG Hospitals, Asian Healthcare Foundation, Institute of Life Sciences and Center for Cellular and Molecular Biology (CCMB) Hyderabad.

 The Delta is the worst variant of the SARS CoV 2 with higher infectivity and is more transmissible, with a diverse set of mutations than any other variant. In India alone, the second wave havoc was caused due to Delta. 

In the study involving 285 patients, 75 per cent who got the monoclonal therapy became RT-PCR negative by the seventh day and 78 per cent of them were relieved of symptoms like fever and cough.

“The results are astonishing and will shape the public health policy for treatment of COVID-19 especially in high-risk individuals, those above the age of 60 or even below 60 but with diabetes, hypertension, obesity, pregnant woman, people with chronic diseases, all will benefit immensely. We have clearly demonstrated in our research that when given at the right time, Monoclonal Therapy stops the progression of the disease completely,” remarked Dr. D Nageshwar Reddy, Chairman, AIG Hospitals.

None of the participants was severely affected and neither did they succumb completely to the disease. When cross-checked, none of the patients reported any post-COVID-19 symptom either.  

Stay connected with us on social media platform for instant update click here to join our  Twitter, & Facebook

We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.

For all the latest Health & Fitness News Click Here 

Read original article here

Denial of responsibility! is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.
Leave a comment